ANIXA BIOSCIENCES RECEIVES NOTICE OF ALLOWANCE FROM CANADIAN INTELLECTUAL PROPERTY OFFICE FOR PATENT COVERING BREAST CANCER VACCINE TECHNOLOGY
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.